Medical Microinstruments secures $110M Series C funding led by Fidelity Management & Research Company for its Symani Surgical System, enhancing microsurgery precision. Blackbird Health receives $17M in Series A funding, led by Define Ventures, expanding youth mental health services nationwide. The Florida-based surgical robotics firm plans to support system commercialization and clinical trials. Pittsburgh’s Blackbird Health aims to scale tech-enabled mental health care offerings and build community partnerships for holistic pediatric treatment.
Medical Microinstruments, a leading surgical robotics company, has announced the successful closure of a $110 million Series C financing round, led by Fidelity Management & Research Company, with continued support from existing investors.
The company’s flagship product, the Symani Surgical System, offers state-of-the-art robotic technology specifically designed for microsurgery and supermicrosurgery. This innovative system enables surgeons to replicate the intricate movements of a human hand at a micro level, enhancing precision and efficacy in soft-tissue and open surgery procedures.
Headquartered in Florida, Medical Microinstruments plans to utilize the funding to advance the commercialization of its robotic platform and undertake crucial clinical studies aimed at validating its effectiveness.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Mark Toland, CEO of MMI, expressed confidence in the company’s vision, stating, “Amidst a backdrop of stagnant investments in medical robotics, this significant support underscores our commitment to providing a less invasive solution for open surgery—a vital market segment that stands to benefit immensely from the utilization of our cutting-edge wristed microinstruments.”
Toland added, “Our Symani Surgical System is poised to broaden patient access to advanced care by empowering a larger pool of surgeons to perform complex and delicate procedures. With the unwavering support of our investors, we remain steadfast in our mission to advance medical technology through robust clinical research and strategic hospital partnerships.”
In parallel news, hybrid youth mental health company Blackbird Health has secured $17 million in Series A funding, bolstering its total capital raise to $23 million. Define Ventures spearheaded the funding round, with participation from Frist Cressey and GreyMatter.
Blackbird Health specializes in providing tech-enabled virtual and in-person mental health care services tailored to children and young adults, addressing a wide range of social, developmental, emotional, and educational challenges. With three brick-and-mortar clinics already established in Pennsylvania and Virginia, the Pittsburgh-based company aims to leverage the newly acquired funds to expand its service offerings, enhance its technological infrastructure, and scale its operations nationwide.
Tom Peterson, CEO of Blackbird Health and former COO and cofounder of Evolent Health, emphasized the company’s commitment to revolutionizing pediatric mental health care delivery. Peterson stated, “As we continue to grow our service offerings and technological capabilities, we remain dedicated to our community-centric approach, forging partnerships with pediatricians and other stakeholders in each region. By fostering a truly integrated, multidisciplinary model of care, we aspire to redefine how children are diagnosed and treated, both in-person and through virtual channels.”